Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 91
Filtrar
1.
Sci Rep ; 12(1): 15922, 2022 09 23.
Artículo en Inglés | MEDLINE | ID: mdl-36151371

RESUMEN

Attention deficit/hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder. Single nucleotide polymorphisms (SNPs) in the Adhesion G Protein-Coupled Receptor L3 (ADGRL3) gene are associated with increased susceptibility to developing ADHD worldwide. However, the effect of ADGRL3 non-synonymous SNPs (nsSNPs) on the ADGRL3 protein function is vastly unknown. Using several bioinformatics tools to evaluate the impact of mutations, we found that nsSNPs rs35106420, rs61747658, and rs734644, previously reported to be associated and in linkage with ADHD in disparate populations from the world over, are predicted as pathogenic variants. Docking analysis of rs35106420, harbored in the ADGLR3-hormone receptor domain (HRM, a common extracellular domain of the secretin-like GPCRs family), showed that HRM interacts with the Glucose-dependent insulinotropic polypeptide (GIP), part of the incretin hormones family. GIP has been linked to the pathogenesis of diabetes mellitus, and our analyses suggest a potential link to ADHD. Overall, the comprehensive application of bioinformatics tools showed that functional mutations in the ADGLR3 gene disrupt the standard and wild ADGRL3 structure, most likely affecting its metabolic regulation. Further in vitro experiments are granted to evaluate these in silico predictions of the ADGRL3-GIP interaction and dissect the complexity underlying the development of ADHD.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Receptores Acoplados a Proteínas G , Trastorno por Déficit de Atención con Hiperactividad/genética , Niño , Polipéptido Inhibidor Gástrico/genética , Polipéptido Inhibidor Gástrico/metabolismo , Genómica , Glucosa , Humanos , Incretinas/genética , Incretinas/metabolismo , Neurogénesis , Receptores Acoplados a Proteínas G/genética , Receptores de Péptidos , Secretina
2.
Turk J Gastroenterol ; 33(8): 704-709, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35946885

RESUMEN

BACKGROUND: To determine the effect of intramuscular administration of Neostigmine® on the visualization of the pancreatic duct on magnetic resonance cholangiopancreatography in patients with recurrent acute pancreatitis or abdominal pain. METHODS: We reviewed patients undergoing magnetic resonance cholangiopancreatography followed by a Neostigmine®-enhanced magnetic resonance cholangiopancreatography. Patients with a history of recurrent acute pancreatitis or abdominal pain who had a magnetic resonance cholangiopancreatography where the pancreatic duct was not entirely seen, were selected to undergo a second magnetic resonance cholangiopancreatography 40 minutes after 0.5 mg Neostigmine®. Images were analyzed by 2 radiologists. The diameter of the pancreatic duct was measured in the head, body, and tail of the pancreas on the baseline images and after Neostigmine®. RESULTS: Ten patients were included, with a median age of 33 years (range 15-61). The maximum diameter of the pancreatic duct increased significantly after Neostigmine® administration in all patients, from 1.84 ± 0.98 to 3.41 ± 1.27 mm in the head, 1.34 ± 0.42 mm to 2.5 ± 0.49 mm in the body and 0.72 ± 0.52 mm to 1.78 ± 0.43 mm in the tail (mean ± SD, P < .0001). Neostigmine® helped to provide better detail of the pancreatic duct anatomy in 4 patients. In 2 patients we confirmed pancreas divisum, in another the Santorini duct was not seen on the baseline images but it was clearly visualized after Neostigmine®, and in the fourth patient, Neostigmine® improved visualization of multiple pancreatic duct stenosis. CONCLUSION: Neostigmine®-magnetic resonance cholangiopancreatography significantly increases the diameter of the pancreatic duct, allowing an accurate morphological evaluation. It could be a cheap alternative to secretin, which is expensive and hardly available.


Asunto(s)
Pancreatitis , Secretina , Dolor Abdominal/diagnóstico por imagen , Dolor Abdominal/tratamiento farmacológico , Dolor Abdominal/etiología , Enfermedad Aguda , Adolescente , Adulto , Colangiopancreatografia Retrógrada Endoscópica , Pancreatocolangiografía por Resonancia Magnética , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Neostigmina , Páncreas/patología , Conductos Pancreáticos/diagnóstico por imagen , Conductos Pancreáticos/patología , Pancreatitis/patología , Adulto Joven
3.
Protein Sci ; 29(4): 893-904, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32020694

RESUMEN

Secretion systems are employed by bacteria to transport macromolecules across membranes without compromising their integrities. Processes including virulence, colonization, and motility are highly dependent on the secretion of effector molecules toward the immediate cellular environment, and in some cases, into the host cytoplasm. In Type II and Type III secretion systems, as well as in Type IV pili, homomultimeric complexes known as secretins form large pores in the outer bacterial membrane, and the localization and assembly of such 1 MDa molecules often relies on pilotins or accessory proteins. Significant progress has been made toward understanding details of interactions between secretins and their partner proteins using approaches ranging from bacterial genetics to cryo electron microscopy. This review provides an overview of the mode of action of pilotins and accessory proteins for T2SS, T3SS, and T4PS secretins, highlighting recent near-atomic resolution cryo-EM secretin complex structures and underlining the importance of these interactions for secretin functionality.


Asunto(s)
Bacterias/química , Proteínas de la Membrana Bacteriana Externa/química , Secretina/química , Bacterias/genética , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/metabolismo , Microscopía por Crioelectrón , Modelos Moleculares , Secretina/genética , Secretina/metabolismo
4.
Acta Physiol (Oxf) ; 222(3)2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29117461

RESUMEN

AIM: We previously reported that atrial natriuretic peptide (ANP) reduces serum amylase and intrapancreatic trypsinogen activation in the onset of acute pancreatitis whereas secretin increases them. In the present work, we sought to establish the effect of ANP and secretin on the inflammatory response and cell death in experimental acute pancreatitis. METHODS: The expression and activity of key inflammatory mediators and apoptosis were evaluated in the presence or absence of the atrial peptide, secretin or both in cerulein-induced acute pancreatitis in rats. Also, ultrastructural changes in pancreatic acinar cells were assessed by transmission electron microscopy. RESULTS: ANP significantly reduced NF-κB activation and TNF-α intrapancreatic levels. Furthermore, it decreased inducible nitric oxide synthase and cyclooxygenase 2 expression and activity while it diminished myeloperoxidase activity. ANP also stimulated apoptosis as shown by caspase-3 expression and activation as well as TUNEL assay. These findings correlated well with the ultrastructural changes observed in the exocrine pancreas. Although secretin reduced various inflammatory markers, it also diminished caspase-3 activation and the overall response was the aggravation of the disease as reflected by the ultrastructural alterations of pancreatic acinar cells. In the presence of ANP, various effects evoked by secretin were antagonized. CONCLUSION: Present findings show that ANP significantly attenuated the severity of acute pancreatitis in the rat by inducing apoptosis and reducing the inflammatory response and further suggest that ANP may have eventual therapeutic implications in the disease and/or in medical interventions at risk of its developing like endoscopic retrograde cholangiopancreatography.


Asunto(s)
Apoptosis/efectos de los fármacos , Factor Natriurético Atrial/farmacología , Inflamación/patología , Pancreatitis/patología , Animales , Femenino , Ratas , Ratas Sprague-Dawley , Secretina/farmacología
5.
J Pediatr ; 188: 186-191, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28693787

RESUMEN

OBJECTIVE: To assess the accuracy and interrater reproducibility of measurements of pancreatic secretory function by magnetic resonance cholangiopancreatography in response to secretin administration and to describe our experience using the technique to noninvasively assess pancreatic secretory function in a pediatric population. STUDY DESIGN: In the accuracy study, phantoms with varying fluid volume (47-206 mL) were imaged using the clinical quantification sequence. Fluid volume was measured by image segmentation (ImageJ). Measurement accuracy was expressed in terms of error (absolute and percent) relative to known fluid volume. In the reproducibility study and clinical experience, 31 patients with suspected pancreatic disease underwent 33 secretin-enhanced magnetic resonance cholangiopancreatography exams. Two-dimensional T2-weighted, fat-saturated single shot fast spin echo sequences were acquired before and after secretin injection (0.2 µg/kg, max 16 µg). Secreted fluid volume (postsecretin minus presecretin) was independently measured by 2 blinded reviewers. Between reviewer measurement reproducibility was assessed based on correlation (Spearman) and bias (Bland-Altman analysis). RESULTS: For the accuracy study, fluid volumes were measured with mean volume errors of -0.3 to +12.5 mL (percent error -0.03% to +9.0%). For the reproducibility study, the mean secreted fluid volumes measured by reviewer 1 and reviewer 2 were 79.1 ± 54.3 mL (range 5.5-215.4) and 77.2 ± 47.1 mL (range 6.7-198.1 mL), respectively. Measured secreted fluid volumes were very strongly correlated (r = 0.922) between reviewers with a bias of only 1.9 mL (95% limits of agreement -40.5 to 44.2). CONCLUSIONS: Measurement of fluid volume by magnetic resonance imaging is highly accurate with <10% (<13 mL) error in measured volume. Measurements of pancreatic secreted fluid volume in response to secretin by magnetic resonance cholangiopancreatography are highly reproducible with a bias of <2 mL between reviewers.


Asunto(s)
Pancreatocolangiografía por Resonancia Magnética , Insuficiencia Pancreática Exocrina/diagnóstico , Pruebas de Función Pancreática , Secretina/farmacocinética , Adolescente , Biomarcadores/análisis , Niño , Humanos , Páncreas Exocrino/metabolismo , Pancreatitis Crónica/etiología , Fantasmas de Imagen , Reproducibilidad de los Resultados
6.
Rev. Méd. Clín. Condes ; 26(5): 634-648, sept. 2015. ilu
Artículo en Español | LILACS | ID: biblio-1128565

RESUMEN

El ultrasonido endoscópico (EUS) ha revolucionado el diagnóstico y el manejo de muchas patologías de la vía digestiva, particularmente la patología pancreática, convirtiéndose en un examen prácticamente imprescindible en el abordaje diagnóstico y terapéutico de un paciente con un problema de páncreas. Es necesario dejar en claro que el método no es único y que para lograr una sensibilidad alta y cumplir el objetivo de realizar lo más adecuado, debe sumarse a otros métodos de acuerdo a cada caso, como la ecografía, la tomografía axial computarizada (TAC), la resonancia magnética (MRI) en sus diferentes modalidades, y las pruebas del laboratorio clínico microbiológico y patología. En este artículo se revisarán algunos casos de enfermedades evaluadas con este método, que muestran por qué el EUS, es una herramienta clave para el médico de urgencias y de consulta externa, el internista, el cirujano, el médico del servicio hospitalario y el personal de salud en general, al momento de definir, clasificar y orientar el manejo de determinadas patologías en el tubo digestivo. El EUS es una importante ayuda y no debe ser extraña al personal médico, debe tenerla presente junto a las demás pruebas diagnósticas en patología pancreática. Se señalarán los aspectos más relevantes en cada caso y las indicaciones del EUS.


Endoscopic ultrasound (EUS) has revolutionized the diagnosis and management of many diseases of the digestive tract, particularly the pancreatic ones, becoming a practically essential test in the diagnosis and therapeutic management of a patient with a pancreatic problem. It's necessary to establish the final diagnosis are necesary many tests to achive high sensitivity. It should join with other methods according to each case, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) in its various forms, and chemical, microbiological and pathology tests. In this article we reviewed some cases of pathologies evaluated by this diagnosis test, which demonstrate why the EUS, is a key for the emergency and outpatient physician, internist, surgeon, doctor of the hospital service and staff health in general, when defining, classifying and guide the management of certain diseases in the digestive tract. The EUS is an important tool and should not be foreign to the medical staff, who must consider it, with other diagnostic tests for pancreatic disease. This article point out the most important aspects in each case and indications of EUS.


Asunto(s)
Humanos , Enfermedades Pancreáticas/diagnóstico por imagen , Endosonografía/métodos , Quiste Pancreático/diagnóstico por imagen , Secretina , Imagen por Resonancia Magnética , Tomografía Computarizada de Emisión , Pancreatocolangiografía por Resonancia Magnética , Pancreatitis Crónica/diagnóstico por imagen , Neoplasias Intraductales Pancreáticas/diagnóstico por imagen
7.
In. Piñol Jiménez, Felipe Neri. Hormonas y neuropéptidos gastrointestinales. La Habana, ECIMED, 2.ed; 2015. , graf.
Monografía en Español | CUMED | ID: cum-61152
8.
In. Paniagua Estévez, Manuel Eusebio; Piñol Jiménez, Felipe Neri. Gastroenterología y hepatología clínica. Tomo 1. La Habana, ECIMED, 2014. , ilus.
Monografía en Español | CUMED | ID: cum-60657
9.
Acta Gastroenterol Latinoam ; 43(4): 294-300, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24516955

RESUMEN

The present tests were undertaken in order to analyze in male Wistar rats the changes in the exocrine and endocrine pancreas and on the interactions that normally evolve in the insulo-pancreon-axis. To evaluate this by a single i.p. Boots secretin injection, glycemia (G), amylasemia (A) and lipasemia (L) were determined. In bile-pancreatic secretion, we analyzed, pre and post-secretin, the following parameters: volume (V), bicarbonate output (BO), amylase output (AO) and lipase output (LO). Three groups of tests were done: a) control (C); b) streptozotocin-treated non-diabetic-rats (St-ND) and c) streptozotocin-treated diabetic animals (St-D) which showed morning glycemia values higher than 16.0 mmol/l. Four months later, under Tiopental i.p anesthesia, a bile-pancreatic fistula was done. Following a 30 min basal period, Boots secretin (20 CU/kg) was i.p injected. Bile-pancreatic secretion put in evidence a significant fall of BO in both St-ND and St-D series. In controls, AO revealed a post-secretin increase of 160%, while in the St-D rats showed a depression of 41%. The behavior of L was different, being augmented (+27%) in the C, while in the St-D rats the response was significantly higher (+95%). In bile-pancreatic-secretion, the fall of BO and AO in the St-ND and St-D series in respect to the C, are probably consequence of the diminishing potentiating effects exerted normally by insulin on the secretin-induced water and bicarbonate secretion of the pancreon units. In contrast, the rising of LO in the St-D, an expression of an enhancing pancreocyte's synthesis and secretion of lipase. The blood changes of A (depression) and of L (increase) in respect to the C values, although without reaching significant level, mirror those observed in bile-pancreatic secretion.


Asunto(s)
Bilis/metabolismo , Diabetes Mellitus Experimental/metabolismo , Páncreas/metabolismo , Amilasas/metabolismo , Animales , Diabetes Mellitus Experimental/enzimología , Lipasa/metabolismo , Masculino , Ratas , Ratas Wistar , Secretina/metabolismo , Estreptozocina
10.
Acta gastroenterol. latinoam ; 43(4): 294-300, 2013 Dec.
Artículo en Español | BINACIS | ID: bin-132727

RESUMEN

The present tests were undertaken in order to analyze in male Wistar rats the changes in the exocrine and endocrine pancreas and on the interactions that normally evolve in the insulo-pancreon-axis. To evaluate this by a single i.p. Boots secretin injection, glycemia (G), amylasemia (A) and lipasemia (L) were determined. In bile-pancreatic secretion, we analyzed, pre and post-secretin, the following parameters: volume (V), bicarbonate output (BO), amylase output (AO) and lipase output (LO). Three groups of tests were done: a) control (C); b) streptozotocin-treated non-diabetic-rats (St-ND) and c) streptozotocin-treated diabetic animals (St-D) which showed morning glycemia values higher than 16.0 mmol/l. Four months later, under Tiopental i.p anesthesia, a bile-pancreatic fistula was done. Following a 30 min basal period, Boots secretin (20 CU/kg) was i.p injected. Bile-pancreatic secretion put in evidence a significant fall of BO in both St-ND and St-D series. In controls, AO revealed a post-secretin increase of 160


, while in the St-D rats showed a depression of 41


. The behavior of L was different, being augmented (+27


) in the C, while in the St-D rats the response was significantly higher (+95


). In bile-pancreatic-secretion, the fall of BO and AO in the St-ND and St-D series in respect to the C, are probably consequence of the diminishing potentiating effects exerted normally by insulin on the secretin-induced water and bicarbonate secretion of the pancreon units. In contrast, the rising of LO in the St-D, an expression of an enhancing pancreocytes synthesis and secretion of lipase. The blood changes of A (depression) and of L (increase) in respect to the C values, although without reaching significant level, mirror those observed in bile-pancreatic secretion.


Asunto(s)
Bilis/metabolismo , Diabetes Mellitus Experimental/metabolismo , Páncreas/metabolismo , Amilasas/metabolismo , Animales , Diabetes Mellitus Experimental/enzimología , Lipasa/metabolismo , Masculino , Ratas , Ratas Wistar , Secretina/metabolismo , Estreptozocina
11.
Acta gastroenterol. latinoam ; Acta gastroenterol. latinoam;43(4): 294-300, 2013 Dec.
Artículo en Español | LILACS, BINACIS | ID: biblio-1157399

RESUMEN

The present tests were undertaken in order to analyze in male Wistar rats the changes in the exocrine and endocrine pancreas and on the interactions that normally evolve in the insulo-pancreon-axis. To evaluate this by a single i.p. Boots secretin injection, glycemia (G), amylasemia (A) and lipasemia (L) were determined. In bile-pancreatic secretion, we analyzed, pre and post-secretin, the following parameters: volume (V), bicarbonate output (BO), amylase output (AO) and lipase output (LO). Three groups of tests were done: a) control (C); b) streptozotocin-treated non-diabetic-rats (St-ND) and c) streptozotocin-treated diabetic animals (St-D) which showed morning glycemia values higher than 16.0 mmol/l. Four months later, under Tiopental i.p anesthesia, a bile-pancreatic fistula was done. Following a 30 min basal period, Boots secretin (20 CU/kg) was i.p injected. Bile-pancreatic secretion put in evidence a significant fall of BO in both St-ND and St-D series. In controls, AO revealed a post-secretin increase of 160


, while in the St-D rats showed a depression of 41


. The behavior of L was different, being augmented (+27


) in the C, while in the St-D rats the response was significantly higher (+95


). In bile-pancreatic-secretion, the fall of BO and AO in the St-ND and St-D series in respect to the C, are probably consequence of the diminishing potentiating effects exerted normally by insulin on the secretin-induced water and bicarbonate secretion of the pancreon units. In contrast, the rising of LO in the St-D, an expression of an enhancing pancreocyte’s synthesis and secretion of lipase. The blood changes of A (depression) and of L (increase) in respect to the C values, although without reaching significant level, mirror those observed in bile-pancreatic secretion.


Asunto(s)
Bilis/metabolismo , Diabetes Mellitus Experimental/metabolismo , Páncreas/metabolismo , Amilasas/metabolismo , Animales , Diabetes Mellitus Experimental/enzimología , Estreptozocina , Lipasa/metabolismo , Masculino , Ratas , Ratas Wistar , Secretina/metabolismo
12.
J. bras. med ; 100(2): 23-28, maio-jun. 2012. tab
Artículo en Portugués | LILACS | ID: lil-682792

RESUMEN

Insuficiência exócrina do pâncreas tem sido revisitada em vários compêndios médicos internacionais e suas novas etiologias avaliadas e reconfirmadas. Neste artigo abordamos as causas mais comuns e tradicionais, pancreatite crônica e fibrose cística, bem como as recentemente mais enfatizadas como doença celíaca e diabetes mellitus. Comentamos a clínica e o diagnóstico precoce e o tratamento com reposição enzimática


Pancreatic exocrine insufficiency has been broadly discussed in international medical literature. New aetiologies have been studied and reaffirmed. In this paper we describe common and traditional causes such as chronic pancreatitis and cystic fibrosis as well as the most recently emphasised celiac disease and diabetes. We also review clinical features, early diagnosis and pancreatic enzyme replacement therapy


Asunto(s)
Humanos , Masculino , Femenino , Fibrosis Quística/complicaciones , Insuficiencia Pancreática Exocrina/etiología , Pancreatitis Crónica/complicaciones , Enfermedad Celíaca , Diabetes Mellitus , Conductos Pancreáticos/fisiología , Diagnóstico Precoz , Secretina , Terapia de Reemplazo Enzimático , Pruebas de Función Pancreática/métodos
13.
Gastroenterology ; 140(4): 1292-302, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21237168

RESUMEN

BACKGROUND & AIMS: Atrial natriuretic factor (ANF) prevents increases in intracellular levels of cAMP that are induced by secretin in the exocrine pancreas. We investigated the contribution of cyclic adenosine monophosphate (cAMP) efflux to ANF inhibition of secretin signaling. METHODS: Intracellular and extracellular cAMP were measured by radio-binding assays in isolated pancreatic acini exposed to secretin and other secretagogues, alone or with ANF. Levels of messenger RNA for multidrug resistance-associated protein (MRP)4, MRP5, and MRP8 were measured by real-time polymerase chain reaction. MRP4 was knocked down in AR42J cells by small interfering RNA. In vivo studies were performed in rats. RESULTS: Pancreatic secretagogues increased levels of intracellular cAMP, but only secretin and vasoactive intestinal peptide promoted cAMP efflux; efflux was increased by ANF, through signaling via natriuretic peptide receptor-C and phospholipase C-protein kinase C. In time-course studies with active phosphodiesterases, levels of intracellular and extracellular cAMP increased earlier after the addition of secretin and ANF (1 min) than after the addition of secretin alone (3 min). Similar kinetic patterns occurred with a phosphodiesterase inhibitor. A probenecid-sensitive transporter mediated cAMP egression. The main cAMP transporter, MRP4, was expressed in AR42J cells and pancreas. cAMP egression occurred in AR42J cells exposed to secretin, but this response was reduced in cells that expressed MRP4 small interfering RNA. In rats, levels of cAMP in plasma and pancreatic juice increased after infusion with secretin alone or secretin plus ANF. CONCLUSIONS: ANF signals via natriuretic peptide receptor-C coupled to the phospholipase C-protein kinase C pathway to increase secretin-induced efflux of cAMP, probably through MPR-4. Cyclic AMP extrusion might be a mechanism, in addition to phosphodiesterase action, to regulate intracellular cAMP levels in pancreatic acinar cells.


Asunto(s)
Factor Natriurético Atrial/metabolismo , AMP Cíclico/metabolismo , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo , Páncreas Exocrino/metabolismo , Animales , Calgranulina A/genética , Calgranulina A/metabolismo , Línea Celular Tumoral , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Neoplasias Pancreáticas , Proteína Quinasa C/metabolismo , ARN Mensajero/metabolismo , ARN Interferente Pequeño , Ratas , Ratas Sprague-Dawley , Secretina/metabolismo , Transducción de Señal/fisiología , Fosfolipasas de Tipo C/metabolismo , Péptido Intestinal Vasoactivo/metabolismo
14.
Int Immunopharmacol ; 8(2): 371-8, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18182253

RESUMEN

Allergy to components of the diet is followed by gut inflammation which in children, sometimes progress to mucosal lesions and anaphylaxis. In newborns suffering of cow's milk allergy, bloody stools, rectal bleeding and ulcerations are found. The rat systemic anaphylaxis is a suitable model to study the intestinal lesions associated to allergy. In the present study we used this model to investigate some mechanisms involved. We found that 15 min after antigen challenge of sensitized rats, hemorrhagic lesions develop in the small intestine. The lesions were more severe in jejunum and ileum compared to duodenum. Pretreatment of the rats with a platelet-activating factor-receptor antagonist (WEB-2170) reduced the lesions whereas inhibition of endogenous nitric oxide by l-NAME, greatly increased the hemorrhagic lesions and mortality. Both, lesions and mortality were reversed by l-arginine. The hemorrhagic lesions were also significantly reduced by the mast cell stabilizers, disodium cromoglycate and ketotifen as well as by neutrophils depletion (with anti-PMN antibodies) or inhibition of selectin binding (by treatment with fucoidan). Thus, the intestinal hemorrhagic lesions in this model are dependent on platelet-activating factor, mast cell granule-derived mediators and neutrophils. Endogenous nitric oxide and supplementation with l-arginine has a protective role, reducing the lesions and preventing mortality. These results contributed to elucidate mechanisms involved in intestinal lesions which could be of relevance to human small bowel injury associated to allergy.


Asunto(s)
Anafilaxia/complicaciones , Hemorragia Gastrointestinal/etiología , Mastocitos/fisiología , Neutrófilos/fisiología , Óxido Nítrico/fisiología , Factor de Activación Plaquetaria/fisiología , Animales , Hemorragia Gastrointestinal/prevención & control , Masculino , Ratas , Ratas Wistar , Secretina/fisiología
15.
Am J Physiol Gastrointest Liver Physiol ; 292(1): G349-57, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16973919

RESUMEN

We previously reported that atrial natriuretic factor (ANF) stimulates pancreatic secretion through NPR-C receptors coupled to PLC and potentiates secretin response without affecting cAMP levels. In the present study we sought to establish the intracellular signaling mechanism underlying the interaction between both peptides. In isolated pancreatic acini 100 nM ANF abolished cAMP accumulation evoked by any dose of secretin. Lower doses of ANF (1 fM, 1 pM, 1 and 10 nM) dose dependently reduced EC50 secretin-evoked cAMP. Although ANF failed to affect cAMP stimulated by amthamine (selective H2 agonist) or isoproterenol (beta-adrenergic agonist), it abolished VIP-induced cAMP formation. ANF inhibitory effect was prevented by U-73122 (PLC inhibitor) and GF-109203X (PKC inhibitor) but unaltered by PKG and nitric oxide synthase inhibition, supporting that the PLC/PKC pathway mediated the effect. ANF response was mimicked by cANP (4-23 amide) and abolished by pertussis toxin, strongly supporting NPR-C receptor activation. In vivo studies showed that ANF at 0.5 microg x kg(-1) x h(-1) enhanced secretion stimulated by 1 U x kg(-1) x h(-1) secretin but at 1 and 2 microg x kg(-1) x h(-1) it abolished secretin response. However, ANF at such doses failed to modify the secretion evoked by carbachol or CCK. Present results show that ANF negatively modulated secretin secretory response and intracellular signaling through the activation of NPR-C receptors coupled to the PLC/PKC pathway. Furthermore, the finding that ANF also inhibited VIP-evoked cAMP supports a selective modulation of class II G-protein coupled receptors by ANF. Present findings suggest that ANF may play a protective role by reducing secretin response to avoid overstimulation.


Asunto(s)
Factor Natriurético Atrial/farmacología , Páncreas/fisiología , Fragmentos de Péptidos/farmacología , Secretina/fisiología , Transducción de Señal/efectos de los fármacos , Animales , AMP Cíclico/metabolismo , Cinética , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Fosfatidilinositoles/metabolismo , Ratas , Ratas Sprague-Dawley
16.
Lab Anim (NY) ; 35(6): 41-9, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16738591

RESUMEN

The diet fed to laboratory animals is one of many variables that can confound research results. The authors investigated the effect of the composition of commercial standard rodent diets on exocrine pancreatic function in rats. They compared two widely used commercial animal diets and found that diet composition greatly influences pancreatic secretion. Their results indicate that commercial diets should conform to the recommended composition requirements to avoid alterations in physiological functions that would eventually affect the results of biomedical research and that investigators should be keenly aware of the composition of the diets being fed to their animals.


Asunto(s)
Alimentación Animal , Páncreas/metabolismo , Jugo Pancreático/metabolismo , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Peso Corporal/fisiología , Masculino , Ratas , Ratas Sprague-Dawley , Secretina/metabolismo , Sincalida/metabolismo
17.
Prensa méd. argent ; Prensa méd. argent;93(2): 119-135, abr. 2006. tab
Artículo en Español | LILACS | ID: lil-482547

RESUMEN

Un objetivo de esta presentación es el de analizar las peculiaridades distintivas de la enzima lipasa proveniente de diferentes fuentes: gástrica (LG), intestinal (LI)hepática (LH), lipoproteica (LLP), pero, en especial, aquella de la pancreática (LP), sobre todo en lo relativo a sus interacciones neuro-hormonales.


Asunto(s)
Humanos , Células Secretoras de Gastrina , Estradiol , Laparotomía , Lipasa , Micelas , Páncreas , Secretina , Somatostatina , Tetragastrina
18.
Prensa méd. argent ; Prensa méd. argent;93(2): 119-135, abr. 2006. tab
Artículo en Español | BINACIS | ID: bin-122232

RESUMEN

Un objetivo de esta presentación es el de analizar las peculiaridades distintivas de la enzima lipasa proveniente de diferentes fuentes: gástrica (LG), intestinal (LI)hepática (LH), lipoproteica (LLP), pero, en especial, aquella de la pancreática (LP), sobre todo en lo relativo a sus interacciones neuro-hormonales.(AU)


Asunto(s)
Humanos , Lipasa/metabolismo , Micelas , Laparotomía , Secretina/análisis , Células Secretoras de Gastrina/metabolismo , Somatostatina/metabolismo , Estradiol , Páncreas/patología , Tetragastrina
19.
Eur J Pharmacol ; 524(1-3): 67-74, 2005 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-16263110

RESUMEN

C-type natriuretic peptide (CNP) is the major natriuretic peptide in the brain and its mRNA has been reported in the central nervous system, which supports local synthesis and its role as a neuromodulator. The aim of the present work was to study the effect of centrally applied CNP on pancreatic secretion. Rats were fitted with a lateral cerebroventricular cannula one-week before secretion studies. The central administration of CNP dose-dependently enhanced pancreatic fluid and protein output. CNP response was diminished by atropine and hexamethonium, but it was abolished by vagotomy. Neither adrenergic antagonists nor the administration of (D-p-Cl-Phe(6),Leu(17))-vasoactive intestinal peptide (VIP antagonist) or N(omega) Nitro-L arginine methyl ester (L-NAME) (nitric oxide synthase inhibitor) affected CNP response. The effect induced by CNP was mimicked by 8-Br-cGMP but not by c-ANP-(4-23) amide (selective agonist of the natriuretic peptide receptor C). Furthermore, CNP interacted with cholecystokinin (CCK) and secretin in the brain to modify pancreatic secretion. Present findings show that centrally applied CNP enhanced pancreatic secretion through a vagal pathway and suggest that CNP response is mediated by the activation of natriuretic peptide guanylyl cyclase coupled receptors in the brain.


Asunto(s)
Encéfalo/efectos de los fármacos , Péptido Natriurético Tipo-C/farmacología , Páncreas/efectos de los fármacos , Nervio Vago/fisiología , Animales , Factor Natriurético Atrial/farmacología , Atropina/farmacología , Encéfalo/fisiología , GMP Cíclico/análogos & derivados , GMP Cíclico/farmacología , Interacciones Farmacológicas , Inhibidores Enzimáticos/farmacología , Bloqueadores Ganglionares/farmacología , Hexametonio/farmacología , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Páncreas/inervación , Páncreas/metabolismo , Parasimpatolíticos/farmacología , Fragmentos de Péptidos/farmacología , Proteínas/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores del Factor Natriurético Atrial/agonistas , Receptores del Factor Natriurético Atrial/fisiología , Secretina/farmacología , Sincalida/farmacología , Tionucleótidos/farmacología , Factores de Tiempo , Vagotomía , Nervio Vago/cirugía , Péptido Intestinal Vasoactivo/farmacología
20.
Am J Physiol Gastrointest Liver Physiol ; 285(5): G929-37, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12829435

RESUMEN

Increasing evidence supports the role of atrial natriuretic factor (ANF) in the modulation of gastrointestinal physiology. The effect of ANF on exocrine pancreatic secretion and the possible receptors and pathways involved were studied in vivo. Anesthetized rats were prepared with pancreatic duct cannulation, pyloric ligation, and bile diversion into the duodenum. ANF dose-dependently increased pancreatic secretion of fluid and proteins and enhanced secretin and CCK-evoked response. ANF decreased chloride secretion and increased the pH of the pancreatic juice. Neither cholinergic nor adrenergic blockade affected ANF-stimulated pancreatic secretion. Furthermore, ANF response was not mediated by the release of nitric oxide. ANF-evoked protein secretion was not inhibited by truncal vagotomy, atropine, or Nomega-nitro-l-arginine methyl ester administration. The selective natriuretic peptide receptor-C (NPR-C) receptor agonist cANP-(4-23) mimicked ANF response in a dose-dependent fashion. When the intracellular signaling coupled to NPR-C receptors was investigated in isolated pancreatic acini, results showed that ANF did not modify basal or forskolin-evoked cAMP formation, but it dose-dependently enhanced phosphoinositide hydrolysis, which was blocked by the selective PLC inhibitor U-73122. ANF stimulated exocrine pancreatic secretion in the rat, and its effect was not mediated by nitric oxide or parasympathetic or sympathetic activity. Furthermore, CCK and secretin appear not to be involved in ANF response. Present findings support that ANF exerts a stimulatory effect on pancreatic exocrine secretion mediated by NPR-C receptors coupled to the phosphoinositide pathway.


Asunto(s)
Factor Natriurético Atrial/fisiología , Guanilato Ciclasa/fisiología , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Receptores del Factor Natriurético Atrial/fisiología , Animales , Factor Natriurético Atrial/administración & dosificación , Factor Natriurético Atrial/farmacología , Presión Sanguínea/efectos de los fármacos , Colecistoquinina/fisiología , Electrólitos/metabolismo , Hidrólisis/efectos de los fármacos , Óxido Nítrico/fisiología , Jugo Pancreático/efectos de los fármacos , Jugo Pancreático/metabolismo , Sistema Nervioso Parasimpático/fisiología , Fosfatidilinositoles/metabolismo , Proteínas/metabolismo , Ratas , Ratas Sprague-Dawley , Secretina/fisiología , Sistema Nervioso Simpático/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA